Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Updated July 2026 The Ozempic and GLP-1 gastroparesis lawsuits involve claims that manufacturers of GLP-1 medications such as Ozempic, Wegovy, Mounjaro, Rybelsus, Trulicity, Zepbound, and Saxenda failed to adequately warn patients and doctors about the potential risk of developing gastroparesis (i.e., stomach paralysis or delayed gastric emptying), a serious gastrointestinal injury that can cause persistent nausea, vomiting, abdominal pain, bloating, dehydration, malnutrition, hospitalization, or the need for feeding tubes or other invasive treatment
For reference, I am 57 and ~130 lbs with a BMI of ~20
Cost in Australia Cost remains a significant barrier
What to track weekly Weigh yourself at the same time on the same day each week, ideally first thing in the morning after using the bathroom
Understanding regulatory status informs conversations with practitioners about monitoring requirements, prescription refill logistics, and insurance coverage pathways
